Cancer News and Research

Latest Cancer News and Research

The $560 million for cancer centers not enough says Cancer Council

The Federal Government has announced a $560 million for new or upgraded cancer centres across Australia this week. The Cancer Council of Australia while welcoming this gesture has said that this is not the complete solution when it comes to helping regional and rural patients of Australia. This statement was made by the CEO Ian Olver who said that this “unprecedented” amount of money can go a long way to help but more support is needed. One of the regional cancer support networks has gone further to criticize the fact that so much is doled out in patient accommodation instead of advanced cancer treatment and care services.

8 Apr 2010

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.

8 Apr 2010

Researchers: VA electronic health records system worth the cost

A new study in the journal Health Affairs finds that while the system, "collectively called Vista, for Veterans Health Information Systems and Technology Architecture" was expensive, it has paid off, The Wall Street Journal reports.

8 Apr 2010

Women living in northeastern U.S. more likely to develop RA: Study

Women living in the northeastern United States are more likely to develop rheumatoid arthritis, suggesting a link between the autoimmune disease and vitamin D deficiency, says a new study led by a Boston University School of Public Health researcher.

8 Apr 2010

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment. The company has started commercial launch of the LINX device at select centers in Europe.

8 Apr 2010

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

7 Apr 2010

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.

7 Apr 2010

Sitting down during hospital room visits induces perception of having stayed longer

Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.

7 Apr 2010

BeaconEquity.com releases investment report on Cell Therapeutics

BeaconEquity.com announces an investment report featuring biotech company Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

7 Apr 2010

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy in two patient subpopulations that are often difficult to treat with current triptan migraine therapies: menstrual migraine and migraine with allodynia.

7 Apr 2010

Jazzercise, Back in the Swing USA partner to promote breast cancer survivorship programs

Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.

7 Apr 2010

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Raptor Pharmaceutical Corp., today announced the engagement of The Trout Group LLC, a leading New York-based investor relations and strategic advisory firm. The Trout Group will work with Raptor to facilitate the Company's exposure to the international capital markets and coordinate their communications with investors worldwide.

7 Apr 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid will initiate European launch of its newest addition to the GeneXpert® family of molecular diagnostic testing systems, the GeneXpert Infinity-48, at the 20th annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Vienna, Austria. The GeneXpert Infinity-48 System is the world's first and only fully-automated, random-access system designed for management of the entire molecular testing workflow — from sample data, cartridge loading and unloading, to final reporting of test results and disposal of cartridges.

7 Apr 2010

Health care reform: Clarification for seniors

From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.

7 Apr 2010

DNA barcoding-sequencing of gene in sand flies identifies two species carrying Leishmania naiffi

In the first survey of sand flies in Panama to use genetic barcoding, scientists at the Smithsonian Tropical Research Institute and Gorgas Memorial Laboratories identified 20 sand fly species from Barro Colorado Island. Two species carried Leishmania naiffi, a parasite that causes cutaneous leishmaniasis: persistent, itchy skin lesions. Three species carried Wolbachia, a bacterial parasite of insects that could contribute to a strategy to control the flies and limit disease transmission.

7 Apr 2010

Updated report analyzing approval rates at FDA published

Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.

7 Apr 2010

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

7 Apr 2010

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

In a broad-based review of studies focused on drugs that treat anxiety, a Saint Louis University doctor found no evidence supporting the use of so-called "natural" treatments in combating the effects of anxiety.

7 Apr 2010

Brazil healthcare market to reach $129.9 billion in 2012

On the road to global economic recovery, the BRIC countries (Brazil, Russia, India and China) are setting up a new scene. Brazil, in particular, is the 9th economy in the world and is expected to reach the 8th position by 2012. New opportunities set a promising healthcare market perspective with a strong potential for further growth.

7 Apr 2010

Folate increases risk of breast cancer in women with certain genetic make-up

In most women folate, a type of B vitamin, reduces the risk of breast cancer. However, in women with a certain genetic make-up it has shown to be the opposite: folate raises the risk of breast cancer.

7 Apr 2010

Cancer News and Research

Latest Cancer News and Research

The $560 million for cancer centers not enough says Cancer Council

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Researchers: VA electronic health records system worth the cost

Women living in northeastern U.S. more likely to develop RA: Study

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

Sitting down during hospital room visits induces perception of having stayed longer

BeaconEquity.com releases investment report on Cell Therapeutics

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

Jazzercise, Back in the Swing USA partner to promote breast cancer survivorship programs

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Health care reform: Clarification for seniors

DNA barcoding-sequencing of gene in sand flies identifies two species carrying Leishmania naiffi

Updated report analyzing approval rates at FDA published

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

Brazil healthcare market to reach $129.9 billion in 2012

Folate increases risk of breast cancer in women with certain genetic make-up

Industry Focus: Cell & Gene Therapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in